Skip to main content
Caplight Logo









Ladder Bio

Ladder Bio

Private
Blue Bell, PennsylvaniaHealthcare & Life Scienceshttps://ladderbio.com

Last Round

Seed

Nov 12, 2025

Total Funding Raised

$5.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ladder Bio operates in Healthcare & Life Sciences and is based in Blue Bell, Pennsylvania. Its latest recorded funding round was a Seed round in November 2025.

Ladder Bio is a biotechnology company developing Spiroligomer™ molecules, a novel therapeutic modality for targeted drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ladder Bio Comparables

Compare Ladder Bio with similar companies based on industry and business-model similarity.

Ladder Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Insamo
86%
Vilya
82%
Unnatural Products
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ladder Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 12, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Ladder Bio Investors

Notable investors and investment history

Ladder Bio investors
InvestorRounds
Medical Excellence CapitalSeed
Hatch BiofundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors grew 81% MoM.

  • May 20, 2026

    Monthly visitors grew 36% MoM, reaching 1.5K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Ladder Bio Filings

Explore SEC and related filing metadata, where available.

Ladder Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ladder Bio's valuation, stock price, and market status.

Is Ladder Bio a public or private company?

Ladder Bio is a private company.

What is the current stock price of Ladder Bio?

Ladder Bio is a private company, so its shares have no public market price. Caplight tracks Ladder Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ladder Bio worth (valuation)?

Valuation information for Ladder Bio is not publicly available.

Can I buy Ladder Bio stock?

Ladder Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ladder Bio's last funding round?

Ladder Bio's most recent funding round was Seed on November 12, 2025.

Who are the main investors in Ladder Bio?

Key investors in Ladder Bio include Medical Excellence Capital.

Will Ladder Bio IPO soon?

No public IPO plans have been announced for Ladder Bio.

How can I track Ladder Bio secondary market activity?

Caplight tracks bids, offers, and trades in Ladder Bio's shares on secondary markets.

Firmographic Details

HeadquartersBlue Bell, Pennsylvania
Employee Range12
Year Founded2020
Last FundingNov 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?